Robert Molander

Robert Molander

Director/Board Member at XSPRAY PHARMA AB

Net worth: 74 818 $ as of 30/03/2024

59 year
Consumer Services
Health Technology
Technology Services

Profile

Robert Molander is currently the Chief Executive Officer at Stratfox Healthcare Group LLC since 2016 and the Director at Xspray Pharma AB since 2022.
Previously, he served as the Chief Commercial Officer at Trialbee AB from 2018 to 2021 and at Infant Bacterial Therapeutics AB from 2020 to 2024.
Mr. Molander holds an MBA from the University of Washington and an undergraduate degree from Miami University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/05/2023 10,000 ( 0.08% ) 74 818 $ 30/03/2024

Robert Molander active positions

CompaniesPositionStart
XSPRAY PHARMA AB Director/Board Member 18/05/2022
Stratfox Healthcare Group LLC Chief Executive Officer 31/12/2015
All active positions of Robert Molander

Former positions of Robert Molander

CompaniesPositionEnd
INFANT BACTERIAL THERAPEUTICS AB Director/Board Member 31/12/2021
Corporate Officer/Principal 01/01/2021
See the detail of Robert Molander's experience

Training of Robert Molander

University of Washington Masters Business Admin
Miami University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Molander's experience

Connections

23

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
XSPRAY PHARMA AB

Health Technology

Private companies3

Technology Services

Infant Bacterial Therapeutics AB

Stratfox Healthcare Group LLC

See company connections
  1. Stock Market
  2. Insiders
  3. Robert Molander